August 4, 2020

Cytonome Researcher Accepted to Elite Leadership Development Program, ISAC

Kirk Mutafopulos, PhD. was recently selected for the International Innovators Program of the International Society for Advancement of Cytometry.

Kirk Mutafopulos, PhD a Harvard graduate and Senior Scientist working in advanced microfluidic device development at Cytonome/ST, was recently selected into a new leadership program within the International Society for Advancement of Cytometry (ISAC). This prestigious ISAC International Innovators (I3) Program is a four year leadership development initiative for innovators developing tools for the advancement of cytometry and single cell analysis and sorting to expand their networks, and undertake a number of other activities with the Society. Additionally, Kirk will be presenting his SAW-based sorting technology at the 2020 Virtual CYTO Conference this week. “We congratulate Kirk for being recognized in this way as an I3 Leader, and very much look forward to seeing how the opportunities presented by this development program not only help in his career, but also the greater Cytometry community”, said John Sharpe, Ph.D., Cytonome’s Chief Operating Officer.

For more details, see

About Cytonome-ST, LLC

Headquartered in Bedford, MA, Cytonome/ST, LLC is a privately held biotechnology instrument design company focused on developing advanced solutions in cell purification for the bioprocessing, industrial, and life science research markets.  With deep engineering expertise in the cytometry field and a strong intellectual property portfolio, Cytonome aims to develop products that simplify existing workflows and enable leading edge basic and translational research.